Humanised anti-MAG antibody or functional fragment thereof
US8071731B2 · kind B2 · utility
2Cited by
13References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 1, 2008 |
| Grant date | Dec 6, 2011 |
| Priority date | — |
| Expiry date | May 24, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to altered antibodies to myelin associated glycoprotein (MAG), pharmaceutical formulations containing them and to the use of such antibodies in the treatment and/or prophylaxis of neurological diseases/disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.